Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Assessment of Financial Toxicity Among Patients With Advanced Lung Cancer in Western China

Bibliographic Data

ID22089262
AuthorsTianqi Xu (0000-0002-1027-4051, Xijing Hospital), Leidi Xu (Xijing Hospital), Hangtian Xi (Xijing Hospital), Yong Zhang (0000-0001-6711-5791, Jiujiang Maternal and Child Care Centres), Ying Zhou (0000-0001-7335-5601, Xijing Hospital), Ning Chang (0000-0002-5244-1858, Xijing Hospital), Wenhui Yang (0009-0003-7692-7777, Xijing Hospital), Yan Zhang (0000-0001-8460-2671, Jiujiang Maternal and Child Care Centres), Ming Wang (0000-0001-8056-4604, Xijing Hospital), Qing Ju (Xijing Hospital), Xuemin Yang (0000-0002-1534-4055, Xijing Hospital), Xiangxiang Chen (0000-0002-2875-1055, Xijing Hospital), Yinggang Che (Xijing Hospital), Fulin Chen (0000-0001-9956-7194, Northwest University), Shuoyao Qu (Xijing Hospital, corresponding author), Jian Zhang (0000-0001-7681-8747, Northwest University, corresponding author)
Year2022
Volume9
Pages754199-754199
Publication date2022-01-12
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2021.754199
PMID35096733
OpenAlexW4205202293
LanguageEN
Citations received2
References cited23

Background: Lung cancer is the leading source of cancer-caused disability-adjusted life years. Medical cost burden impacts the well-being of patients through reducing income, cutting daily expenses, curtailing leisure activities, and depleting exhausting savings. The COmprehensive Score for Financial Toxicity (COST) was created and validated by De Souza and colleagues. Our study intends to measure the financial burdens of cancer therapy and investigate the link between financial toxicity and health-related quality of life (HRQoL) in an advanced lung cancer population. Methods: Patients aged ≥ 18 years with confirmed stage III to IV lung cancer were eligible. The COST questionnaire verified by de Souza et al. was used to identify financial toxicity. Multivariable linear regression analysis with log transformation univariate analysis and Pearson correlations were used to perform the analysis. Results: The majority of the patients (90.8%, n = 138/152) had an annual income of $50,000 ($7,775). The cohort's insurance situation was as follows: 64.5% of the cohort had social insurance, 20.4% had commercial insurance, and 22.0% had both. Patients who were younger age (50–59, P < 0.001), employed but on sick leave, and had lower income reported increased levels of financial toxicity ( P < 0.05). The risk factors for high financial toxicity: (i) younger age (50–59), (ii) <1 month of savings, and (iii) being employed but on sick leave. Increased financial toxicity is moderately correlated with a decrease in QoL. Conclusion: Poorer psychological status and specific demographics are linked to increased financial toxicity (lower COST). Financial toxicity has a modest relationship with HRQoL and may have a clear link with HRQoL measurements

Business · Cancer · Cohort · Environmental health · Lung cancer · Multivariate analysis · Population · Toxicity · Univariate analysis · Economic and Financial Impacts of Cancer · Health Systems, Economic Evaluations, Quality of Life · Medicine · Multiple and Secondary Primary Cancers · Finance · Internal Medicine

  • Assessment of the financial toxicity in patients with differentiated thyroid cancer

    Open Access•Jun Zhou, Zhou Jun et al.•Frontiers in Public Health•2025

  • Financial toxicity and its association with quality of life and psychological distress among patients with gynecologic cancers receiving radiotherapy in China

    Open Access•Jianjun Zhang, Jing Zhao et al.•Frontiers in Public Health•2026

  • Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer

    Jennifer S Temel, Joseph A Greer et al.•New England Journal of Medicine•2010

  • Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

    Open Access•Christina Fitzmaurice, Global Burden of Disease Cancer Collaboration et al.•JAMA Oncology•2019

  • Inequality and the health-care system in the USA

    Open Access•Samuel L Dickman, Samuel Dickman et al.•The Lancet•2017

  • Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

    Christina Fitzmaurice, Global Burden of Disease Cancer Collaboration et al.•JAMA Oncology•2017

Citations per year2
Citation span2025 - 2026 (2)
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae